Q: Hi,
Now that the IPO has come out and the feeding frenzy pushed the stock to approx $71 on day one, it has retraced quite a bit from that one day high but still double the IPO price today (Dec 15). I will wait for this one to settle a bit more in the next several weeks but just curious what you think a fair entry price range would be given they are already profitable vs several other recent IPO's in the same space or other space for that matter? Or should one wait for the outcome of phase 2 and 3 trials before dipping their toes in on this one? I would only initiate a 1/3 position.
I realize the euphoria right now is around covid but longer term they seem to have a unique product/platform that could be applicable elsewhere, ie AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health.
Cheers....
Now that the IPO has come out and the feeding frenzy pushed the stock to approx $71 on day one, it has retraced quite a bit from that one day high but still double the IPO price today (Dec 15). I will wait for this one to settle a bit more in the next several weeks but just curious what you think a fair entry price range would be given they are already profitable vs several other recent IPO's in the same space or other space for that matter? Or should one wait for the outcome of phase 2 and 3 trials before dipping their toes in on this one? I would only initiate a 1/3 position.
I realize the euphoria right now is around covid but longer term they seem to have a unique product/platform that could be applicable elsewhere, ie AbCellera and Invetx Expand Multi-Year Antibody Discovery Collaboration in Animal Health.
Cheers....